openPR Logo
Press release

Advancements and Opportunities in the Global Computer-Aided Drug Discovery Market

04-22-2024 11:24 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Advancements and Opportunities in the Global Computer-Aided

Global Computer-Aided Drug Discovery Market Overview

The global computer-aided drug discovery market is witnessing growth due to the rise in chronic and unknown diseases and accelerated drug development. While a shortage of skilled labor hampers growth, various growth prospects in developed and developing economies are fostering market expansion.

Download Report: https://www.alliedmarketresearch.com/request-sample/17201

Impact of COVID-19 on the Market:

Despite the challenges posed by the COVID-19 pandemic to many industries, the computer-aided drug discovery market experienced positive growth. Increased R&D efforts by scientists, researchers, biotech, and biopharmaceutical companies aimed at combating the disease contributed to this growth.

Therapeutic Area Insights:

In 2021, the oncology segment dominated the market, capturing nearly one-fourth of the global share. This segment is expected to grow at a CAGR of 12.29% during the forecast period, driven by increased R&D for new drug discovery.

End-User Analysis:

The pharmaceutical companies segment led the market in 2021, accounting for over two-fifths of the total market share. Meanwhile, the biotechnology companies segment is forecasted to grow at the fastest CAGR of 11.97% from 2022 to 2030, propelled by increased R&D for biologic drug development.

Regional Market Dynamics:

North America led the market in 2021, capturing more than one-third of the global market share. Conversely, the Asia-Pacific region is projected to grow at the fastest CAGR of 12.84% during the forecast period, driven by a growing number of biotech companies and increased R&D investment.

Key Industry Players:

Schrödinger, Inc.
Bayer AG
Aragen Life Sciences Pvt. Ltd.
Aris Pharmaceuticals, Inc.
AstraZeneca
Albany Molecular Research Inc. (AMRI)
Bioduro-Sundia
Charles River Laboratories

Request Customization: https://www.alliedmarketresearch.com/request-for-customization/A16823

Key Benefits for Stakeholders:

Comprehensive analysis of market size, current trends, and future prospects to identify investment opportunities.
Forecast for the computer-aided drug discovery market from 2021 to 2031 to guide stakeholders in leveraging market opportunities.
Detailed regional analysis to identify growth opportunities across different regions.
In-depth analysis of key players' profiles and growth strategies to understand the competitive landscape.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advancements and Opportunities in the Global Computer-Aided Drug Discovery Market here

News-ID: 3471578 • Views:

More Releases from Allied Market Research

Armed for Advancement : Unveiling the $14.15 Billion Global Small Arms Market Forecasted for 2032 with a 5.3% CAGR by Allied Market Research
Armed for Advancement : Unveiling the $14.15 Billion Global Small Arms Market Fo …
Allied Market Research published a report, titled, "Small Arms Market by Type, Action End Use Sector, and Region. By Type, (Pistol, Shotgun, Revolver, and Others). Based on Action (Automatic and Semi-Automatic). By End Use Sector (Civil & Commercial and Defense). Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global small arms industry generated $8.42 billion in 2022, and is anticipated to generate $14.15 billion by 2032,
Flexible Battery Market Analysis, Trends, Top Manufacturers, Share, Growth, Statistics, Opportunities & Forecast to 2032
Flexible Battery Market Analysis, Trends, Top Manufacturers, Share, Growth, Stat …
Allied Market Research published an exclusive report, titled, "Flexible Battery Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Voltage, by Rechargeability, by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032". Global Flexible Battery Market was valued at $0.17 billion in 2022 and is projected to reach $1.5 billion by 2032, growing at a CAGR of 24.9% from 2023 to 2032. Download Research Report Sample & TOC :
Industry 5.0 Market Size is Expected to Reach $637.4 Billion by 2032
Industry 5.0 Market Size is Expected to Reach $637.4 Billion by 2032
Allied Market Research published an exclusive report, titled, "Industry 5.0 Market Size, Share, Competitive Landscape and Trend Analysis Report by Technology, by End-Use Vertical : Global Opportunity Analysis and Industry Forecast, 2023-2032". The Global Industry 5.0 Market was valued at $129.1 billion in 2022, and is projected to reach $637.4 billion by 2032, growing at a CAGR of 17.3% from 2023 to 2032. Download Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/A313229 Industry 5.0
Leak Detection Market Growth, Latest Trends, Competitive Scenario, and Regional Analysis, 2023 to 2032
Leak Detection Market Growth, Latest Trends, Competitive Scenario, and Regional …
Allied Market Research published an exclusive report, titled, "Leak Detection Market by Technology (Acoustic/Ultrasound, Fiber Optic, Pressure-flow Deviation Methods, Mass/Volume Balance, Thermal Imaging, and Others) and End User (Oil and Gas, Chemical Plants, Water Treatment Plants, Thermal Power Plants, Mining and Slurry, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". The Global Leak Detection Market was valued at $4.7 billion in 2022, and is projected to reach $8.2 billion by

All 5 Releases


More Releases for R&D

Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports. Transforming Pharmaceutical R&D with Data In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow